JPS5610119A - Manufacture of b type hepatitis infection preventive vaccine - Google Patents

Manufacture of b type hepatitis infection preventive vaccine

Info

Publication number
JPS5610119A
JPS5610119A JP8549379A JP8549379A JPS5610119A JP S5610119 A JPS5610119 A JP S5610119A JP 8549379 A JP8549379 A JP 8549379A JP 8549379 A JP8549379 A JP 8549379A JP S5610119 A JPS5610119 A JP S5610119A
Authority
JP
Japan
Prior art keywords
manufacture
type hepatitis
hepatitis infection
preventive vaccine
infection preventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8549379A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5721246B2 (enFirst
Inventor
Maupa Fuiritsupu
Emu Gudeyuu Arain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpha Therapeutic Corp
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Priority to JP8549379A priority Critical patent/JPS5610119A/ja
Priority to GB8106701A priority patent/GB2065473B/en
Priority to PCT/US1980/000834 priority patent/WO1981000050A1/en
Priority to DE19803049690 priority patent/DE3049690A1/de
Publication of JPS5610119A publication Critical patent/JPS5610119A/ja
Publication of JPS5721246B2 publication Critical patent/JPS5721246B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP8549379A 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine Granted JPS5610119A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP8549379A JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine
GB8106701A GB2065473B (en) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine
PCT/US1980/000834 WO1981000050A1 (en) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine
DE19803049690 DE3049690A1 (de) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8549379A JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine

Publications (2)

Publication Number Publication Date
JPS5610119A true JPS5610119A (en) 1981-02-02
JPS5721246B2 JPS5721246B2 (enFirst) 1982-05-06

Family

ID=13860454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8549379A Granted JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine

Country Status (3)

Country Link
JP (1) JPS5610119A (enFirst)
GB (1) GB2065473B (enFirst)
WO (1) WO1981000050A1 (enFirst)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
JPH08839B2 (ja) * 1984-03-07 1996-01-10 アンステイテユ・パストウ−ル Ｂ型肝炎ウイルスの表面抗原と重合ヒト血清アルブミンレセプタ−とを有する粒子を含むワクチン製造に有用な組成物、前記の如き粒子を産生し得る動物細胞、並びにこれら細胞を得るための方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
FR2561256B1 (fr) * 1984-03-16 1987-01-02 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite
NL8401066A (nl) * 1984-04-04 1985-11-01 Stichting Centraal Lab Werkwijze ter bereiding van preparaten, die de humorale en cellulaire immuunreaktiviteit vergroten.
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
EP0384058A1 (en) * 1989-02-09 1990-08-29 Development Center For Biotechnology Isolation of hepatitis B surface antigen from transformed yeast cells
AU657168B2 (en) * 1991-09-18 1995-03-02 Amgen, Inc. Hepatitis B vaccine with bile salt adjuvant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (enFirst) * 1962-01-03
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
FR2336141A1 (fr) * 1975-12-23 1977-07-22 Trepo Christian Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPH08839B2 (ja) * 1984-03-07 1996-01-10 アンステイテユ・パストウ−ル Ｂ型肝炎ウイルスの表面抗原と重合ヒト血清アルブミンレセプタ−とを有する粒子を含むワクチン製造に有用な組成物、前記の如き粒子を産生し得る動物細胞、並びにこれら細胞を得るための方法
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法

Also Published As

Publication number Publication date
WO1981000050A1 (en) 1981-01-22
JPS5721246B2 (enFirst) 1982-05-06
GB2065473B (en) 1984-02-29
GB2065473A (en) 1981-07-01

Similar Documents

Publication Publication Date Title
DE3067014D1 (en) Preparation of 2-phenylalkanes
JPS55136116A (en) Preparation of silicon
JPS536428A (en) Preventing method of virus infection
JPS56102786A (en) Preparation of concentrated virus group
JPS5692922A (en) Manufacture of silicone
GB2058053B (en) Preparation of diesterdiamides
IL60784A0 (en) Preparation of hydroxycoumarans
JPS57144227A (en) Manufacture of b type hepatitis vaccine
JPS5610119A (en) Manufacture of b type hepatitis infection preventive vaccine
IL61355A0 (en) Preparation of 3-phenoxy-benzaldehydes
JPS5598119A (en) Manufacture of interferon
GB2041781B (en) Die-pulling of silicon
JPS5650904A (en) Manufacture of innerrplastic polyvinylchloride
IL61008A0 (en) Preparation of 2-alkyl-and 2-aryl-trimethylphenols
IL59190A (en) Preparation of metachloroanilines
IL60337A0 (en) Preparation of dihydrodimethyl-7-hydroxybenzofuran
GB2051785B (en) Preparation of benzophenone-azines
GB2061917B (en) Preparation of aminopropionamides
JPS55149114A (en) Preparation of silicon
GB2053254B (en) Preparation of trialkoxysilanols
IL60756A0 (en) Preparation of 4-fluoro-3-phenoxytoluene
IL60580A (en) Preparation of trifluoromethyl-naphthalenes
JPS55167295A (en) Improved manufacture of 3300demethylfortimicins
JPS55166239A (en) Preparation of bagginnbox
JPS569286A (en) Manufacture of ceramic